Karyopharm Therapeutics Inc (FRA:25K)
€ 0.5734 -0.0194 (-3.27%) Market Cap: 84.88 Mil Enterprise Value: 143.15 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 64/100

Karyopharm Therapeutics Inc - Investor And Analyst ASH Event (Virtual) Transcript

Dec 08, 2020 / 06:00PM GMT
Release Date Price: €12.94 (-1.07%)
Operator

Hello. My name is Keith, and I will be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics ASH 2020 Investor Conference Call. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company's request.

I would now like to turn the call over to Mr. Ian Karp, Karyopharm's Senior Vice President, Investor and Public Relations.

Ian Karp
Karyopharm Therapeutics Inc. - SVP of Investor & Public Relations

Great. Thanks so much, and thank you all for joining us on today's conference call to discuss important clinical data presented at the American Society of Hematology 2020 Annual Meeting. This is Ian Karp, and I'm joined today by Dr. Michael Kauffman, Chief Executive Officer; Dr. Jatin Shah, Chief Medical Officer; as well as my 2 guests on today's call, who will join us a bit later: Dr. James Berenson, Founder, President and Medical and Scientific Director of the Institute for Myeloma and Bone Cancer Research; and Dr. Timothy Pardee, Director

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot